make WWAY your homepage  Become a fan on facebook  Follow us on twitter  Receive RSS Newsfeeds  MEMBERS: Register | Login

FDA revokes approval of Avastin for breast cancer

READ MORE: FDA revokes approval of Avastin for breast cancer

By LAURAN NEERGAARD
AP Medical Writer

WASHINGTON, DC (AP) -- The Food and Drug Administration has declared the blockbuster drug Avastin should no longer be used in breast cancer patients because there's no proof it extends their lives - and it is causing dangerous side effects.

Friday's ruling was long expected, but is sure to disappoint women who say they've run out of other options.

FDA Commissioner Dr. Margaret Hamburg called the decision difficult but said patients must have confidence that drugs sold for their condition are effective.

Avastin won't stop selling, as it's also used to treat colon cancer and certain other tumors, but the FDA ruling is expected to influence insurance coverage. Medicare says it will continue to cover Avastin while it evaluates whether a change is needed.

(Copyright 2011 by The Associated Press. All Rights Reserved.)

Disclaimer: Comments posted on this, or any story are opinions of those people posting them, and not the views or opinions of WWAY NewsChannel 3, its management or employees. You can view our comment policy here.

»

Reply

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

To prevent automated spam submissions leave this field empty.
CAPTCHA
Please re-enter the code shown in the image below.